All In MedTech

Device Trial Radar · NCT02777593

Evaluation of the GORE® TBE Device in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2

Evaluation of the GORE® TAG® Thoracic Branch Endoprosthesis (TBE Device) in the Treatment of Lesions of the Aortic Arch and Descending Thoracic Aorta, Zone 2

Last checked: Nov 20, 2026Latest source record: Sep 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingResults posted on the registry

Status

Active, not recruiting

Enrollment

250

Actual

Start

Sep 6, 2016

Primary completion

Apr 12, 2021

Study completion Dec 2027

Sponsor

Lead sponsor
W.L.Gore & AssociatesNot on our public-company list
Sponsor type
Industry
First posted
May 19, 2016

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to determine whether the GORE® TAG® Thoracic Branch Endoprosthesis is safe and effective in treating lesions of the aortic arch and descending thoracic aorta, requiring Zone 2 proximal implantation of the device.

Conditions

  • Aortic Aneurysm, Thoracic
  • Aorta; Lesion

Interventions

  • GORE® TAG® Thoracic Branch EndoprosthesisDevice

    Endovascular repair with the TBE Device

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of Participants With Primary Endpoint Success for Zone 2Time frame: 12 Months

Locations

35 sites in 1 country. Site status is shown where the registry gives one.

  • Keck Medical Center of USC

    Los Angeles, California

  • Cedar-Sinai Medical Center

    Los Angeles, California

  • Leland Stanford Junior University

    Stanford, California

32 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.